Editors   FDA: NeuralStem's Fetal Stem Cell Study for Lou Gehrig's Patients on Hold   2/25/2009 9:50:00 AM    
The US FDA put a hold on NeuralStem's clinical study amyotrophic lateral sclerosis, more commonly known as Lou Gehrig’s Disease.

The company had intended to test its ability to safely inject fetal stem cells into the spinal cords of patients and fully replace the damaged spinal cord cells.

See Editors   Sensationalized: AP Says Fetal Stem Cells Trigger Tumors in Boy   2/18/2009 8:10:00 AM    
The Associated Press has sensationalized an old stem tourism case where Russian stem therapy from 2002-2004 went horribly wrong.

An Israeli boy with a fatal brain disease developed tumors after receiving stem cell injections created from multiple fetal stem cells (some were from a female).

Doctors say his brain disease wasn't conducive to stem cell therapy in the first place.

Editors   First Human Trials for Stem Cell Therapy on Lou Gehrig Patients   12/18/2008 11:56:00 AM    
The US FDA has cleared the way for Neuralstem, Inc. to conduct clinical trials on ALS (Lou Gehrig's disease) patients by injecting stem cells into their spinal cord.